UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Do pharmacokinetic polymorphisms explain treatment failure in high-risk patients with neuroblastoma?

Bellanti, F; Kagedal, B; Della Pasqua, O; (2011) Do pharmacokinetic polymorphisms explain treatment failure in high-risk patients with neuroblastoma? EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY , 67 S87-S107. 10.1007/s00228-010-0966-3.

Full text not available from this repository.
Type: Article
Title: Do pharmacokinetic polymorphisms explain treatment failure in high-risk patients with neuroblastoma?
DOI: 10.1007/s00228-010-0966-3
Keywords: Science & Technology, Life Sciences & Biomedicine, Pharmacology & Pharmacy, PHARMACOLOGY & PHARMACY, Neuroblastoma, Pharmacogenetics, Pharmacokinetics, Cytotoxic drugs, Modelling & simulation, PKPD modelling, ACUTE LYMPHOBLASTIC-LEUKEMIA, REFRACTORY SOLID TUMORS, MYCN-AMPLIFIED NEUROBLASTOMA, BONE-MARROW-TRANSPLANTATION, JAPANESE CANCER-PATIENTS, ACID TRANSPORTERS LAT1, ACUTE MYELOID-LEUKEMIA, OF-PEDIATRIC-ONCOLOGY, HIGH-DOSE MELPHALAN, CELL LUNG-CANCER
UCL classification: UCL > School of Life and Medical Sciences
UCL > School of Life and Medical Sciences > Faculty of Life Sciences
UCL > School of Life and Medical Sciences > Faculty of Life Sciences > UCL School of Pharmacy
UCL > School of Life and Medical Sciences > Faculty of Life Sciences > UCL School of Pharmacy > Pharmacology
URI: http://discovery.ucl.ac.uk/id/eprint/1401006
Downloads since deposit
0Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item